Cost-Effectiveness Analysis of Lipegfilgrastim as Primary Prophylaxis in Women With Breast Cancer in Australia--A Modeled Economic Evaluation
Sep 1, 2018, 00:00 AM
10.1016/j.jval.2018.07.106
https://www.valueinhealthjournal.com/article/S1098-3015(18)32463-X/fulltext
Section Title :
Section Order :
114
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32463-X&doi=10.1016/j.jval.2018.07.106